ImmunogenX and Mayo Clinic Celiac Disease Study Published in Gastroenterology - Business Wire

ImmunogenX is pleased to report the successful completion of the CeliacShield™ trial (NCT03585478), focused on treating celiac disease (CeD) patients,

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--ImmunogenX is pleased to report the successful completion of the CeliacShield trial (NCT03585478), focused on treating celiac disease (CeD) patients, will be p… [+2704 chars]

full article...